Page last updated: 2024-09-04

cyc 202 and arsenic trioxide

cyc 202 has been researched along with arsenic trioxide in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (arsenic trioxide)	Trials (arsenic trioxide)	Recent Studies (post-2010) (arsenic trioxide)
979	7	393	3,119	160	1,507

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Murakami, H	1

Reviews

1 review(s) available for cyc 202 and arsenic trioxide

Article	Year
[New strategy for the treatment of multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:12 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Dexamethasone; Drug Design; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Oxides; Prognosis; Protease Inhibitors; Purines; Pyrazines; Roscovitine; Thalidomide; Transplantation Conditioning	2005

Article

Year

[New strategy for the treatment of multiple myeloma].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:12

Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Dexamethasone; Drug Design; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Multiple Myeloma; Oxides; Prognosis; Protease Inhibitors; Purines; Pyrazines; Roscovitine; Thalidomide; Transplantation Conditioning

2005